Doximity, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Shareholder voteSep 2 →InsidersNo open-market buys. 4 insiders sold $1.8M, all 13 sales on a 10b5-1 plan.→HoldersBlackRock 8.0%Vanguard Portfolio 3.6%Vanguard 3.3%→PeersClosest companies: WAY, OMDA, PATH→
From the filings
Figures
- Revenue
- $655.6Mlast 12 months
- Net income
- $167.1Mlast 12 months
- Operating cash flow
- $306.3Mlast 12 months
- Cash and equivalents
- $273.6Mat the last balance sheet
- Shares outstanding
- 179.8M shareson issue